TriMas (NASDAQ:TRS – Get Free Report) is expected to post its Q2 2026 results before the market opens on Thursday, July 30th. Analysts expect the company to post earnings of $0.49 per share and revenue of $178.4380 million for the quarter. TriMas has set its FY 2026 guidance at 1.500-1.70 EPS. Individuals may review the information on the company’s upcoming Q2 2026 earning results page for the latest details on the call scheduled for Thursday, July 30, 2026 at 10:00 AM ET.
TriMas (NASDAQ:TRS – Get Free Report) last issued its quarterly earnings results on Thursday, April 30th. The industrial products company reported $0.24 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.48 by ($0.24). TriMas had a return on equity of 8.38% and a net margin of 93.79%.The business had revenue of $168.28 million during the quarter, compared to the consensus estimate of $158.24 million. During the same quarter in the previous year, the business earned $0.46 earnings per share. The firm’s revenue was up 10.3% compared to the same quarter last year. On average, analysts expect TriMas to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.
TriMas Trading Down 0.8%
Shares of NASDAQ TRS opened at $40.22 on Wednesday. TriMas has a 1 year low of $30.43 and a 1 year high of $45.42. The stock has a market cap of $1.44 billion, a P/E ratio of 1.67 and a beta of 0.59. The firm has a 50-day moving average of $41.31 and a 200 day moving average of $38.33. The company has a debt-to-equity ratio of 0.27, a current ratio of 4.85 and a quick ratio of 4.50.
TriMas Dividend Announcement
Wall Street Analyst Weigh In
Several research firms have recently issued reports on TRS. Zacks Research upgraded shares of TriMas from a “strong sell” rating to a “hold” rating in a report on Tuesday, May 5th. Weiss Ratings upgraded TriMas from a “buy (b-)” rating to a “buy (b)” rating in a research note on Tuesday, June 23rd. Three research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, TriMas currently has an average rating of “Moderate Buy” and an average target price of $41.50.
Get Our Latest Analysis on TriMas
Insider Transactions at TriMas
In other news, Director Herbert K. Parker sold 15,000 shares of the company’s stock in a transaction that occurred on Tuesday, June 30th. The shares were sold at an average price of $45.03, for a total value of $675,450.00. Following the transaction, the director owned 57,762 shares in the company, valued at approximately $2,601,022.86. This represents a 20.62% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 17.50% of the company’s stock.
Hedge Funds Weigh In On TriMas
Hedge funds have recently added to or reduced their stakes in the company. Man Group plc bought a new position in TriMas during the 4th quarter valued at about $206,000. Simplex Trading LLC grew its stake in shares of TriMas by 264.7% in the fourth quarter. Simplex Trading LLC now owns 9,846 shares of the industrial products company’s stock worth $349,000 after acquiring an additional 7,146 shares during the period. PharVision Advisers LLC bought a new stake in shares of TriMas in the third quarter worth approximately $207,000. Moneta Group Investment Advisors LLC purchased a new position in shares of TriMas during the third quarter valued at approximately $204,000. Finally, Captrust Financial Advisors purchased a new position in shares of TriMas during the second quarter valued at approximately $355,000. 99.42% of the stock is currently owned by hedge funds and other institutional investors.
TriMas Company Profile
TriMas Corporation is a diversified industrial company headquartered in Bloomfield Hills, Michigan. Established in 1980, TriMas has built a global reputation for designing and manufacturing specialized products that serve a wide array of end markets. The company operates through multiple segments, each focused on high-demand niches where engineered solutions and rigorous quality standards are essential.
The Packaging segment supplies closures, dispensing systems and related components for the personal care, household chemicals, food and beverage, and pharmaceutical markets.
See Also
- Five stocks we like better than TriMas
- These 3 Stocks Have Soared in 2026—Can They Keep Climbing?
- Hasbro’s Earnings Beat Shows Why This Is No Longer Just a Toy Story
- Rambus: Another AI Phoenix Ready to Rise From the Ashes of Correction
- Chips & Clips: Memory Tariffs Rewire Tech Supply Chains
Receive News & Ratings for TriMas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TriMas and related companies with MarketBeat.com's FREE daily email newsletter.
